During the last session, Hims & Hers Health Inc. (NYSE:HIMS)’s traded shares were 1.87 million. At the end of the trading day, the stock’s price was $4.36, reflecting an intraday loss of -0.46% or -$0.02. The 52-week high for the HIMS share is $11.33, that puts it down -159.86 from that peak though still a striking 37.61% gain since the share price plummeted to a 52-week low of $2.72. The company’s market capitalization is $846.84M, and the average intraday trading volume over the past 10 days was 2.1 million shares, and the average trade volume was 2.06 million shares over the past three months.
Hims & Hers Health Inc. (HIMS) received a consensus recommendation of an Overweight from analysts. That translates to a mean rating of 2.30. HIMS has a Sell rating from 0 analyst(s) out of 7 analysts who have looked at this stock. 3 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 4 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -$0.1.
Hims & Hers Health Inc. (NYSE:HIMS) trade information
Hims & Hers Health Inc. (HIMS) registered a -0.46% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -0.46% in intraday trading to $4.36 this Wednesday, 06/22/22, hitting a weekly high. The stock’s 5-day price performance is 13.84%, and it has moved by 24.22% in 30 days. Based on these gigs, the overall price performance for the year is -60.00%. The short interest in Hims & Hers Health Inc. (NYSE:HIMS) is 8.98 million shares and it means that shorts have 3.42 day(s) to cover.
The consensus price target of analysts on Wall Street is $6.29, which implies an increase of 30.68% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $4.00 and $10.00 respectively. As a result, HIMS is trading at a discount of -129.36% off the target high and 8.26% off the low.
Hims & Hers Health Inc. (HIMS) estimates and forecasts
Statistics show that Hims & Hers Health Inc. has outperformed its competitors in share price, compared to the industry in which it operates. Hims & Hers Health Inc. (HIMS) shares have gone down -29.56% during the last six months, with a year-to-date growth rate more than the industry average at 16.67% against -3.00. In the rating firms’ projections, revenue will increase 55.20% compared to the previous financial year.
Revenue for the current quarter is expected to be $102.91 million as predicted by 6 analyst(s). Meanwhile, a consensus of 6 analyst(s) estimates revenue growth to $106.36 million by the end of Sep 2022.
While earnings are projected to return -375.60% in 2022, the next five years will return 38.20% per annum.
Hims & Hers Health Inc. is due to release its next quarterly earnings between August 09 and August 15. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Hims & Hers Health Inc. (NYSE:HIMS)’s Major holders
Hims & Hers Health Inc. insiders own 21.99% of total outstanding shares while institutional holders control 45.65%, with the float percentage being 58.52%. Redpoint Management, Llc is the largest shareholder of the company, while 165 institutions own stock in it. As of Mar 30, 2022, the company held over 10.4 million shares (or 5.26% of all shares), a total value of $55.41 million in shares.
The next largest institutional holding, with 10.2 million shares, is of Institutional Venture Management XV, LLC’s that is approximately 5.16% of outstanding shares. At the market price on Mar 30, 2022, these shares were valued at $54.38 million.
Also, the Mutual Funds coming in first place with the largest holdings of Hims & Hers Health Inc. (HIMS) shares are Vanguard Total Stock Market Index Fund and Vanguard Small-Cap Index Fund. Data provided on Mar 30, 2022 indicates that Vanguard Total Stock Market Index Fund owns about 2.92 million shares. This amounts to just over 1.48 percent of the company’s overall shares, with a $15.56 million market value. The same data shows that the other fund manager holds slightly less at 2.44 million, or about 1.24% of the stock, which is worth about $13.02 million.